Onesource Specialty Pharma Ltd
ONESOURCEOnesource Specialty Pharma Ltd
ONESOURCE


Price Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
-82.94 | 38.36 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
47.90 | 6.10 | 0.56% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
OneSource Specialty Pharma Ltd is a contract development and manufacturing organization specializing in complex biologics, biosimilars, and vaccines.
Peers
Compare with peersGet more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 2.30 | 22.40 | 137.99 | 41.41 | 176.15 | 891.10 | ||||||
Raw Materials | 0.00 | 20.52 | 160.34 | 21.55 | 70.51 | 760.69 | ||||||
Power & Fuel Cost | 5.15 | 8.65 | 26.68 | 20.55 | 20.42 | |||||||
Employee Cost | 25.07 | 31.22 | 56.97 | 72.80 | 79.36 | |||||||
Selling & Administrative Expenses | 13.77 | 10.82 | 29.48 | 43.01 | 59.94 | |||||||
Operating & Other expenses | 39.71 | 22.22 | -44.11 | 526.20 | 170.61 | |||||||
EBITDA | -81.40 | -71.03 | -91.37 | -642.70 | -224.69 | 130.41 | ||||||
Depreciation/Amortization | 28.81 | 34.40 | 70.35 | 108.88 | 76.29 | 175.64 | ||||||
PBIT | -110.21 | -105.43 | -161.72 | -751.58 | -300.98 | -45.23 | ||||||
Interest & Other Items | 27.77 | 15.80 | 68.02 | 47.55 | 89.42 | 131.73 | ||||||
PBT | -137.98 | -121.23 | -229.74 | -799.13 | -390.40 | -176.96 | ||||||
Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.98 | ||||||
Net Income | -137.98 | -121.23 | -229.74 | -799.13 | -390.40 | -183.94 | ||||||
EPS | -1,460.09 | -974.39 | -842.63 | -363.79 | -97.54 | -45.96 | ||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Peers & Comparison
Health CareBiotechnology
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Onesource Specialty Pharma Ltd | -39.08 | 38.36 | — |
Biocon Ltd | 40.72 | 1.65 | 0.14% |
Sai Life Sciences Ltd | 167.67 | 14.24 | — |
Panacea Biotec Ltd | -1,799.31 | 2.49 | — |
Price Comparison
Compare ONESOURCE with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Dec 2024
Shareholding History
Mutual Funds Holding Trend
No mutual funds holding trends are available
Top 5 Mutual Funds holding Onesource Specialty Pharma Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 1.6008% | Percentage of the fund’s portfolio invested in the stock 1.05% | Change in the portfolio weight of the stock over the last 3 months 1.05% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 32/98 (+64) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.0112% | Percentage of the fund’s portfolio invested in the stock 1.98% | Change in the portfolio weight of the stock over the last 3 months 1.98% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 36/37 (+1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.6813% | Percentage of the fund’s portfolio invested in the stock 1.14% | Change in the portfolio weight of the stock over the last 3 months 1.14% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 47/67 (+16) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
ONESOURCE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Net Loss of OneSource Specialty Pharma reported to Rs 68.85 crore in the quarter ended December 2024 as against net loss of Rs 130.16 crore during the previous quarter ended December 2023. Sales rose 598.38% to Rs 392.56 crore in the quarter ended December 2024 as against Rs 56.21 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales392.5656.21 598 OPM %36.48-18.68 - PBDT102.78-35.36 LP PBT34.02-54.88 LP NP-68.85-130.16 47 Powered by Capital Market - Live
OneSource Specialty Pharma will hold a meeting of the Board of Directors of the Company on 29 January 2025.Powered by Capital Market - Live
The equity shares of Onesource Specialty Pharma (Scrip Code: 544292) are listed effective 24 January 2025 and admitted to dealings on the Exchange in the list of ''T'' Group SecuritiesPowered by Capital Market - Live
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant